Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postmarketing Study Of Lybrel In Relation To Venous Thromboembolism

NCT01297348 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01297348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01297348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postmarketing Study Of Lybrel In Relation To Venous Thromboembolism
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 31, 2007
Completion date
April 30, 2012
Enrollment
598,682 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism, sinus thrombosis, intracranial, venous thrombosis